JERUSALEM, Israel - An experimental treatment developed at Israel's Hadassah-University Medical Center has a 90% success rate at bringing patients with multiple myeloma into remission. Hadassah-University Medical Center in Jerusalem’s Ein Kerem has announced an “unprecedented achievement” in the treatment of multiple myeloma cancer – the second-most common hematological disease. It accounts for one-tenth of all
BOSTON - Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development. However, for the vast majority of those mutations, researchers are unsure of how they contribute to cancer because there’s no easy way to study them in animal models. In an advance that could help scientists make a dent in
NEW YORK - Imagine using your cellphone to control the activity of your own cells to treat injuries and disease. It sounds like something from the imagination of an overly optimistic science fiction writer. But this may one day be a possibility through the emerging field of quantum biology. Over the past few decades, scientists
DURHAM, N.C. —Researchers at Duke University may one day give countless heart attack patients a second chance for a healthy life. Using rodents, study authors have revealed a potential way to turn back the clock following a heart attack. The human heart is capable of incredible feats, beating over 100,000 times and pumping over 2,000
BOSTON - A team of Harvard Medical School scientists say they've come up with a new drug cocktail of molecules that they say can successfully regenerate the hair cells in the inner ear that enable hearing — a potentially groundbreaking treatment for hearing loss. As detailed in a new paper published in the Proceedings of the National Academy
NEW YORK - In a significant groundbreaking medical development, researchers have created a tiny device, smaller than a grain of rice, to deliver drugs directly to the pancreatic tumor. In the near future, this implantable nanofluidic device could be a game changer in treating pancreatic cancer. Nanomedicine experts at Houston Methodist Academic Institute developed the
BLOOMFIELD HILLS–Zivo Bioscience Inc., a biotech and agriculture-tech research and development company developing medicines and nutritional products from algae cultures, announced a $1 million unsecured six-month loan from Chairman and CEO John Payne. The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to
LONDON, UK - Scientists have developed a test to identify which blood-cancer patients will benefit the most from a drug that can stop their cancer from returning. The test, which looks for genetic clues in cancer cells, can identify the ten per cent of patients who see little effect from life-saving lenalidomide. This could spare them
OXFORD, UK - A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound. Oxford University researchers have worked in collaboration with industry leaders NuCana to assess a novel
ANN ARBOR - Michigan Medicine has announced its plans to begin drone delivery of prescriptions to patients in Washtenaw County in 2024. The delivery service will employ Zipline’s new platform that uses electric drones to provide quiet, fast, and precise autonomous delivery directly to homes. According to Zipline, the drones are designed to sound like
